medline.ch Respirationstrakt Zystische Fibrose

	Plethysmography as a Complementary Tool for Monitoring Response to CFTR Modulator Therapy in Children with Cystic Fibrosis: A Real-World Study. J Clin Med Postek MA, Walicka-Serzysko K, Borawska-Kowalczyk U, Milczewska J, Zybert K, Wo, Wo, Sands D. PMID: 43030499 [PubMed]
	Antisense Oligonucleotides as Quantitative Modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): A Threshold-Based Therapeutic Framework for Class I and Class V CFTR Mutations. BioDrugs Battistini M, Lagostena L, Balestra D, Pinotti M, Baroni D. PMID: 43024219 [PubMed - as supplied by publisher]
	Prevalence of the F508del variant in patients with cystic fibrosis in northeastern Brazil: clinical and laboratory factors. Respir Res Clin Pract de Araújo EM, Silva CCE, Nogueira HBR, de Araújo LCB, Silveira LCB, Bessa OAAC. PMID: 43017625 [PubMed - indexed for MEDLINE]
	Pectoralis muscle features assessed by chest CT and their associations with clinical and functional outcomes in children and adolescents with cystic fibrosis: a cross-sectional study. Respir Res Clin Pract da Costa MS, Amor-Barbosa M, Sbruzzi M, Vendrusculo FM, Fischer DL, Carvalho FM, Andrade RGF, Pinto LA, Donadio MVF. PMID: 43017613 [PubMed - indexed for MEDLINE]
	Real-world outcomes of elexacaftor/tezacaftor/ivacaftor in a cohort of children and adolescents with cystic fibrosis in Brazil. Respir Res Clin Pract Cohen RWF, Coelho PF, Rocha LY, Moreira JVDC, Barboza N, Marins KAC, Meyer VMC, Costa PFBM, Folescu TW. PMID: 43017612 [PubMed - indexed for MEDLINE]
	Spontaneous clearance and real-world management after first asymptomatic MRSA isolation in pediatric cystic fibrosis. BMC Pulm Med Kavgac, Yalç, Sunman B, Kayao, Kantemir T, Emiralioglu N, Dogru D, Özçelik U. PMID: 43015729 [PubMed - indexed for MEDLINE]
	Longitudinal change in FEV(1) in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor in France: a prospective observational study. Lancet Respir Med Burgel PR, Lafourcade A, Da Silva J, Durieu I, Macey J, Danner-Boucher I, de Miranda S, Audousset C, Murris-Espin M, Renaud-Picard B, Morisse-Pradier H, Hamidfar R, Chiron R, Guillaumot A, Belleguic C, Mely L, Reynaud-Gaubert M, Mankikian J, Ramel S, Fanton A, Priou P, Montcouquiol S, Leroy S, Richaud-Thiriez B, Douvry B, Mulette P, Arnouat B, Dupuy-Grasset M, Campbell K, Choinier P, Boldron A, Poulet C, Allou N, Bessou A, Martin C, French Cystic Fibrosis Reference Network study group. PMID: 43014331 [PubMed - as supplied by publisher]
	Cystic fibrosis: remarkable success but still notÂ atÂ theÂ finish line. Proc (Bayl Univ Med Cent) Jung F, Rosenblatt R. PMID: 43013617 [PubMed - as supplied by publisher]
	Digital health in cystic fibrosis across the eHealth life-cycle: why successful innovation requires more than randomised trials. Breathe (Sheff) Vagg T, Roukema J, Edmondson C, Albon D, Ranganathan SC, Plant BJ. PMID: 43011906 [PubMed]
	SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential. Mol Ther Adv Liang X, Liu Y, Jia S, Zhang K, Xu J. PMID: 42999678 [PubMed]
	Factors Guiding Gastrostomy Tube Decision-Making for Caregivers of Children With Cystic Fibrosis: A Scoping Review. Pediatr Pulmonol Rahimian A, Givens N, Godfrey C, Goebel K, Ohamadike C, Dickinson KM. PMID: 42997966 [PubMed - indexed for MEDLINE]
	Health-Related Quality of Life and Preference-Based Utility Index in People With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A National Registry Study. Pediatr Pulmonol Hegelund MH, Bryrup T, Henriksen EH, Højte C, Katzenstein TL, Jeppesen M, Qvist T, Olesen HV, Olsen MF, TransformCF Study Group. PMID: 42995692 [PubMed - indexed for MEDLINE]
	Cystic Fibrosis in Egypt. Pediatr Pulmonol Nasr SZ, Fleifil S, Fouda E, Kamel TB, Ali HA, Naguib ML, ElAttar MM, Elbasha NRM, Taha O, Sarhan DT, Tamer D, Regal MEE, Elmeazawy R, Fasseeh N, Libik MM, Macek M Jr. PMID: 42995683 [PubMed - indexed for MEDLINE]
	Understanding Quality of Life in Pediatric Cystic Fibrosis: Insights From a Multicenter Cohort Study Across Colombia. Pediatr Pulmonol Dueñas-Meza E, De la Hoz-Diaz Granados DC, Proaños NJ, Pulido S, Portella T, Jurado J, Giraldo-Cadavid LF. PMID: 42995682 [PubMed - indexed for MEDLINE]
	Current knowledge, key gaps, and opportunities for future research on high-impact, modifiable lifestyle behaviors to promote healthy aging in adults with cystic fibrosis in the era of modulator therapy. J Cyst Fibros Bathgate CJ, Riekert KA, Fedele DA, Everhart RS, Dickinson KM, Saavedra MT, Oates GR, Russell KA, Cravens R, Frederick CA. PMID: 42995032 [PubMed - as supplied by publisher]
	Changes in neuropsychiatric symptoms after switching from elexacaftor/tezacaftor/ivacaftor to vanzacaftor/tezacaftor/deutivacaftor: A single-center experience. Respir Med Galipean J, Hadjiliadis D, Kane S, Longacre W, Hong G. PMID: 42994765 [PubMed - indexed for MEDLINE]
	Mucus Plugging Across Multiple Chronic Respiratory Diseases: A Systematic Review and Meta-analysis. Lung Du D, Liu S, Zhang Y, Gao L, Zeng T, An N, Chen F, Luo F, Shen Y. PMID: 42993210 [PubMed - indexed for MEDLINE]
	The Association Between Meconium Ileus and Nutritional and Pulmonary Outcomes in Children With Cystic Fibrosis. Pediatr Pulmonol Sanders DB, Shah Y, Cordova JMG, Saunders JL, Ren CL, Owora AH. PMID: 42978396 [PubMed - indexed for MEDLINE]
	Assessing infection and inflammation in people with cystic fibrosis using their breath: A pilot longitudinal study. J Breath Res Gao A, Ackah-Cudjoe J, Hashemi M, Durfey S, Mckone EF, Wagner BD, Singh PK, Hill JE. PMID: 42976381 [PubMed - as supplied by publisher]
	Integrating US Registry data to reveal social and environmental determinants impacting lung function decline in cystic fibrosis patients. J Appl Stat Andrinopoulou ER, Gecili E, Szczesniak RD. PMID: 42974119 [PubMed]

Artikel 1 - 20 / 20300

Seite 1 von 1015



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung